LMNA and familial dilated cardiomyopathy: The same group, two years later, proposed a six-miRNA panel (let-7a-5p, let-7g-5p, miR-16-2-3p, miR-210-3p, miR-215-5p, and miR-629-5p) to differentiate DCM subjects with pathogenic BAG3 or LMNA variants from wild-type variant carriers.